Vir Biotechnology, Inc.
VIR
$6.12
-$0.17-2.70%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -104.59M | -213.72M | -138.38M | -65.28M | -115.97M |
| Total Depreciation and Amortization | 2.89M | 2.90M | 4.26M | 4.52M | 4.48M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 31.07M | 21.85M | 58.62M | 33.52M | 36.32M |
| Change in Net Operating Assets | -17.00M | 17.49M | -2.35M | -82.15M | -32.75M |
| Cash from Operations | -87.64M | -171.48M | -77.85M | -109.39M | -107.93M |
| Capital Expenditure | -2.41M | -2.36M | -666.00K | -1.87M | -1.54M |
| Sale of Property, Plant, and Equipment | 2.46M | 5.00K | 379.00K | 533.00K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 140.69M | 120.95M | 211.89M | 29.76M | -103.28M |
| Cash from Investing | 140.74M | 118.60M | 211.61M | 28.42M | -104.81M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 178.00K | -40.00K | -69.00K | -69.00K | 200.00K |
| Issuance of Common Stock | 1.25M | 71.00K | 3.01M | 221.00K | 1.77M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -165.00K | -- | -- | -- | -287.00K |
| Cash from Financing | 1.26M | 31.00K | 2.94M | 152.00K | 1.68M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 54.37M | -52.85M | 136.70M | -80.82M | -211.06M |